352 related articles for article (PubMed ID: 10660629)
21. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
Wang S; Nath N; Minden A; Chellappan S
EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.
Lee RJ; Albanese C; Fu M; D'Amico M; Lin B; Watanabe G; Haines GK; Siegel PM; Hung MC; Yarden Y; Horowitz JM; Muller WJ; Pestell RG
Mol Cell Biol; 2000 Jan; 20(2):672-83. PubMed ID: 10611246
[TBL] [Abstract][Full Text] [Related]
23. GCIP, a novel human grap2 and cyclin D interacting protein, regulates E2F-mediated transcriptional activity.
Xia C; Bao Z; Tabassam F; Ma W; Qiu M; Hua S; Liu M
J Biol Chem; 2000 Jul; 275(27):20942-8. PubMed ID: 10801854
[TBL] [Abstract][Full Text] [Related]
24. Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage.
Park DS; Morris EJ; Bremner R; Keramaris E; Padmanabhan J; Rosenbaum M; Shelanski ML; Geller HM; Greene LA
J Neurosci; 2000 May; 20(9):3104-14. PubMed ID: 10777774
[TBL] [Abstract][Full Text] [Related]
25. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes.
Hauck L; Hansmann G; Dietz R; von Harsdorf R
Circ Res; 2002 Nov; 91(9):782-9. PubMed ID: 12411392
[TBL] [Abstract][Full Text] [Related]
27. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.
Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP
Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886
[TBL] [Abstract][Full Text] [Related]
28. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.
Strobeck MW; Fribourg AF; Puga A; Knudsen ES
Oncogene; 2000 Apr; 19(15):1857-67. PubMed ID: 10773875
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the cyclin E gene by transcription factor E2F1.
Ohtani K; DeGregori J; Nevins JR
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12146-50. PubMed ID: 8618861
[TBL] [Abstract][Full Text] [Related]
30. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K; Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
[TBL] [Abstract][Full Text] [Related]
31. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
Flemington EK; Speck SH; Kaelin WG
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):6914-8. PubMed ID: 8346196
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the retinoblastoma-dependent Mdm2 and E2F-1 signaling pathways during neuronal apoptosis.
Trinh E; Boutillier AL; Loeffler JP
Mol Cell Neurosci; 2001 Feb; 17(2):342-53. PubMed ID: 11178871
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F.
Guo K; Walsh K
J Biol Chem; 1997 Jan; 272(2):791-7. PubMed ID: 8995365
[TBL] [Abstract][Full Text] [Related]
34. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
[TBL] [Abstract][Full Text] [Related]
35. Differential activities of E2F family members: unique functions in regulating transcription.
Pierce AM; Schneider-Broussard R; Philhower JL; Johnson DG
Mol Carcinog; 1998 Jul; 22(3):190-8. PubMed ID: 9688145
[TBL] [Abstract][Full Text] [Related]
36. Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest.
Knudsen KE; Fribourg AF; Strobeck MW; Blanchard JM; Knudsen ES
J Biol Chem; 1999 Sep; 274(39):27632-41. PubMed ID: 10488103
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
Iwanaga R; Ohtani K; Hayashi T; Nakamura M
Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
[TBL] [Abstract][Full Text] [Related]
38. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
Keenan SM; Lents NH; Baldassare JJ
J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
[TBL] [Abstract][Full Text] [Related]
39. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
[TBL] [Abstract][Full Text] [Related]
40. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
Zacksenhaus E; Jiang Z; Phillips RA; Gallie BL
EMBO J; 1996 Nov; 15(21):5917-27. PubMed ID: 8918469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
